EGFR reporting in stage IV adenocarcinoma of the lung: Demographic predictors of EGFR testing and survival.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.9100
Abstract: 9100Background: Tyrosine Kinase inhibitors (TKI) have changed the treatment paradigm in patients with stage IV adenocarcinoma of the lung (AdenoCa) harboring epidermal growth factor receptor (EGFR)... read more here.
Keywords: adenocarcinoma lung; reporting stage; stage adenocarcinoma; egfr reporting ... See more keywords
Major arterial resection for stage 3 adenocarcinoma of the pancreas.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.362
Abstract: 362Background: Stage 3 pancreas ductal adenocarcinoma (PDAC) is defined by arterial involvement, and its resection remains controversial. The objective of this study was to evaluate clinical and on... read more here.
Keywords: arterial resection; resection stage; major arterial; stage adenocarcinoma ... See more keywords
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.1017902
Abstract: Objectives We investigated how the prognosis for Norwegian patients with stage IV, adenocarcinoma (NSCLC) has developed during the last decade, to observe if increased survival coincides with the introduction of immunotherapy at a population level.… read more here.
Keywords: stage adenocarcinoma; survival; months months; stage ... See more keywords